• Culture, context, and ethics in the therapeutic use of hallucinogens: Psychedelics as active super-placebos?

    2022
    David, Dupuis Samuel, Veissière
  • Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives

    2022
    Ayse Ceren, Kaypak Amir, Raz
  • Ceremonial ‘Plant Medicine’ use and its relationship to recreational drug use: an exploratory study

    2019
    C., Dorsen J., Palamar M.G., Shedlin
  • Understanding ayahuasca effects in major depressive disorder treatment through in vitro metabolomics and bioinformatics.

    2023
    Flávia S., Zandonadi A.A.R., Silva A.A.S., Melo
  • Pharmacokinetic and Pharmacodynamic Interaction of the Ayahuasca Constituents Harmine and Dimethyltryptamine (DMT) in the Rat Brain

    2023
    Klemens, Egger Frederik, Gudmundsen Naja Støckel, Jessen Christina, Baun Sandra, Pötzsch Vladimir, Shalgunov Matthias M., Herth Boris B., Quednow Chantal, Martin-Soelch Dario A., Dornbierer Milan, Scheidegger Paul, Cumming Mikael, Palner
  • Psychedelics: Alternative and Potential Therapeutic Options for Treating Mood and Anxiety Disorders

    2022
    Henry, Lowe Ngeh, Toyang Blair, Steele Justin, Grant Amza, Ali Lorenzo, Gordon Wilfred, Ngwa
  • Interpol Review of Drug Analysis 2019-2022

    2023
    David, Love Nicole S., Jones
  • Significance of mammalian N, N-dimethyltryptamine (DMT): A 60-year-old debate

    2022
    Javier Hidalgo, Jiménez José Carlos, Bouso
  • A Prehistoric Mural in Spain Depicting Neurotropic Psilocybe Mushrooms?

    2011
    Brian P., Akers Juan Francisco, Ruiz Alan, Piper Carl Anton Paul, Ruck
  • Hallucinogens and Altered States of Consciousness in Cusco, Peru: A Path to Local Power during Wari State Expansion

    2019
    Véronique, Bélisle
  • 3387 papers
  • « Previous
  • Next »